Imuvant - A Novel Adjuvant; Efficacy and Safety Properties in Hyogen Vaccine

The aim of this study by Ceva was to assess the safety of Hyogen® and evaluate the boosting effect of the J5 component of Imuvant™ on the efficacy of Hyogen® vaccine in 3-week-old piglets, write Miklós Tenk, Anna Kollár, Ferenc Misák, Mariann Ivók, Nimród Pálmai and Zoltán Pénzes, Ceva.
calendar icon 19 February 2016
clock icon 2 minute read
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.